← Open Payments lookup

PHYLLIS TARALLO: Open Payments

NPI 1043217300 · TEANECK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,989 in 197 payments from 28 companies in 2025. Trend: 2023 $690 · 2024 $913 · 2025 $3,989

Food & beverage: $3,172Education: $418Long term medical supply or device loan: $399
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation17$606
Daiichi Sankyo Inc.25$423
E.R. Squibb & Sons, L.L.C.34$413
GlaxoSmithKline, LLC.9$305
Gilead Sciences, Inc.7$264
Incyte Corporation7$208
AstraZeneca Pharmaceuticals LP11$186
Janssen Biotech, Inc.13$183
Regeneron Healthcare Solutions, Inc.14$164
TAIHO ONCOLOGY, INC.8$155

Products named: KISQALI, ENHERTU, Trodelvy, OJJAARA, LIBTAYO, LONSURF, OPDIVO, VERZENIO.

Industry payments across NJ — which companies pay providers there.